176 related articles for article (PubMed ID: 18474463)
1. A double-blind, randomised, vehicle-controlled clinical study to evaluate the efficacy of MAS065D in limiting the effects of radiation on the skin: interim analysis.
Leonardi MC; Gariboldi S; Ivaldi GB; Ferrari A; Serafini F; Didier F; Mariani L; Castiglioni S; Orecchia R
Eur J Dermatol; 2008; 18(3):317-21. PubMed ID: 18474463
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis.
Primavera G; Carrera M; Berardesca E; Pinnaró P; Messina M; Arcangeli G
Cutan Ocul Toxicol; 2006; 25(3):165-71. PubMed ID: 16980242
[TBL] [Abstract][Full Text] [Related]
3. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
Abramovits W; Boguniewicz M;
J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
[TBL] [Abstract][Full Text] [Related]
4. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer.
Freedman GM; Anderson PR; Li J; Eisenberg DF; Hanlon AL; Wang L; Nicolaou N
Am J Clin Oncol; 2006 Feb; 29(1):66-70. PubMed ID: 16462506
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of concomitant tumour bed boost with whole breast irradiation in patients with locally advanced breast cancer undergoing breast-conserving therapy.
Jalali R; Malde R; Bhutani R; Budrukkar A; Badwe R; Sarin R
Breast; 2008 Feb; 17(1):64-70. PubMed ID: 17851077
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pruritus in mild-to-moderate atopic dermatitis with a topical non-steroidal agent.
Veraldi S; De Micheli P; Schianchi R; Lunardon L
J Drugs Dermatol; 2009 Jun; 8(6):537-9. PubMed ID: 19537379
[TBL] [Abstract][Full Text] [Related]
7. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
Röper B; Kaisig D; Auer F; Mergen E; Molls M
Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
[TBL] [Abstract][Full Text] [Related]
8. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
Belloni G; Pinelli S; Veraldi S
Eur J Dermatol; 2005; 15(1):31-6. PubMed ID: 15701590
[TBL] [Abstract][Full Text] [Related]
9. Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair) in the management of mild-to-moderate atopic dermatitis in adults.
Abramovits W; Hebert AA; Boguniewicz M; Kempers SE; Tschen E; Jarratt MT; Lucky AW; Cornelison RL; Swinyer LJ; Jones TM
J Dermatolog Treat; 2008; 19(6):327-32. PubMed ID: 18728923
[TBL] [Abstract][Full Text] [Related]
10. A potent steroid cream is superior to emollients in reducing acute radiation dermatitis in breast cancer patients treated with adjuvant radiotherapy. A randomised study of betamethasone versus two moisturizing creams.
Ulff E; Maroti M; Serup J; Falkmer U
Radiother Oncol; 2013 Aug; 108(2):287-92. PubMed ID: 23827771
[TBL] [Abstract][Full Text] [Related]
11. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy.
Osako T; Oguchi M; Kumada M; Nemoto K; Iwase T; Yamashita T
Jpn J Clin Oncol; 2008 May; 38(5):334-8. PubMed ID: 18417501
[TBL] [Abstract][Full Text] [Related]
12. Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial.
Kirova YM; Fromantin I; De Rycke Y; Fourquet A; Morvan E; Padiglione S; Falcou MC; Campana F; Bollet MA
Radiother Oncol; 2011 Aug; 100(2):205-9. PubMed ID: 21624699
[TBL] [Abstract][Full Text] [Related]
13. Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: a phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5).
Magnusson M; Höglund P; Johansson K; Jönsson C; Killander F; Malmström P; Weddig A; Kjellén E
Eur J Cancer; 2009 Sep; 45(14):2488-95. PubMed ID: 19540105
[TBL] [Abstract][Full Text] [Related]
14. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study.
Polgár C; Major T; Fodor J; Németh G; Orosz Z; Sulyok Z; Udvarhelyi N; Somogyi A; Takácsi-Nagy Z; Lövey K; Agoston P; Kásler M
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1173-81. PubMed ID: 15519789
[TBL] [Abstract][Full Text] [Related]
15. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of 15% azelaic acid in psoriasis vulgaris: a randomized, controlled clinical trial.
Iraji F; Faghihi G; Siadat AH; Enshaieh S; Shahmoradi Z; Joia A; Soleimani F
J Drugs Dermatol; 2010 Aug; 9(8):964-8. PubMed ID: 20684146
[TBL] [Abstract][Full Text] [Related]
17. Moist skin care can diminish acute radiation-induced skin toxicity.
Momm F; Weissenberger C; Bartelt S; Henke M
Strahlenther Onkol; 2003 Oct; 179(10):708-12. PubMed ID: 14566480
[TBL] [Abstract][Full Text] [Related]
18. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial.
Wells M; Macmillan M; Raab G; MacBride S; Bell N; MacKinnon K; MacDougall H; Samuel L; Munro A
Radiother Oncol; 2004 Nov; 73(2):153-62. PubMed ID: 15542162
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
